Inventor
ARNOLD LEE D
US39 patents
⚠️ This page may combine multiple inventors who share the name “ARNOLD LEE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PARDES BIOSCIENCES INC
6 patentsUS11174231B1Nov 16, 2021
Inhibitors of cysteine proteases and methods of use thereof
PARDES BIOSCIENCES INC36 citations96
US11124497B1Sep 21, 2021
Inhibitors of cysteine proteases and methods of use thereof
PARDES BIOSCIENCES INC57 citations96
US11312704B2Apr 26, 2022
Inhibitors of cysteine proteases and methods of use thereof
PARDES BIOSCIENCES INC1 citations71
US12145911B2Nov 19, 2024
Inhibitors of cysteine proteases and methods of use thereof
PARDES BIOSCIENCES INC0 citations60
US11524940B1Dec 13, 2022
Inhibitors of cysteine proteases and methods of use thereof
PARDES BIOSCIENCES INC0 citations60
US11472793B2Oct 18, 2022
Inhibitors of cysteine proteases and methods of use thereof
PARDES BIOSCIENCES INC0 citations60
ABBOTT GMBH & CO KG
5 patentsUS7332497B2Feb 19, 2008
Pyrazolopyrimidines as therapeutic agents
ABBOTT GMBH & CO KG217 citations98
US6660744B1Dec 9, 2003
Pyrazolopyrimidines as therapeutic agents
ABBOTT GMBH & CO KG331 citations98
US6713474B2Mar 30, 2004
Pyrrolopyrimidines as therapeutic agents
ABBOTT GMBH & CO KG59 citations92
US7091227B2Aug 15, 2006
Benzothiazole derivatives
ABBOTT GMBH & CO KG29 citations90
US7369946B2May 6, 2008
Method of identifying inhibitors of Tie-2
ABBOTT GMBH & CO KG1 citations45
ASSEMBLY BIOSCIENCES INC
5 patentsUS11814376B2Nov 14, 2023
Hepatitis b core protein modulators
ASSEMBLY BIOSCIENCES INC0 citations60
US10968211B2Apr 6, 2021
Hepatitis B core protein modulators
ASSEMBLY BIOSCIENCES INC0 citations60
US11078170B2Aug 3, 2021
Cyclic sulfamide compounds and methods of using same
ASSEMBLY BIOSCIENCES INC1 citations59
US11040965B2Jun 22, 2021
Process for making Hepatitis B core protein modulators
ASSEMBLY BIOSCIENCES INC0 citations49
US10987360B2Apr 27, 2021
Hepatitis B core protein modulators
ASSEMBLY BIOSCIENCES INC0 citations49
OSI PHARM INC
4 patentsUS7534797B2May 19, 2009
6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors
OSI PHARM INC100 citations98
US7923555B2Apr 12, 2011
Fused bicyclic mTor inhibitors
OSI PHARM INC15 citations91
US7820662B2Oct 26, 2010
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
OSI PHARM INC12 citations91
US7943767B2May 17, 2011
Fused bicyclic mTOR inhibitors
OSI PHARM INC9 citations83
ABBOTT LAB
3 patentsBASF AG
3 patentsUS6462036B1Oct 8, 2002
Tricyclic pyrazole derivatives
BASF AG38 citations89
US6451834B1Sep 17, 2002
Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives
BASF AG14 citations82
US6534655B1Mar 18, 2003
Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
BASF AG1 citations48
ARNOLD LEE D
3 patentsUS8101613B2Jan 24, 2012
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
ARNOLD LEE D10 citations80
US8735405B2May 27, 2014
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
ARNOLD LEE D0 citations48
US8575164B2Nov 5, 2013
Combination cancer therapy
ARNOLD LEE D1 citations46
KINNATE BIOPHARMA INC
3 patentsUS11345681B1May 31, 2022
Inhibitors of fibroblast growth factor receptor kinases
KINNATE BIOPHARMA INC4 citations72
US10894788B2Jan 19, 2021
Inhibitors of cyclin-dependent kinases
KINNATE BIOPHARMA INC5 citations72
US11390618B2Jul 19, 2022
Inhibitors of cyclin-dependent kinases
KINNATE BIOPHARMA INC0 citations62